A comprehensive view of u.s. food and drug administration (fda). This page highlights a small sample of our full coverage.
For real-time access, please log in to your Government & Public Policy Market Intelligence Service.
Recent Articles
sample of recent headlines, press releases and get more..
Emergent BioSolutions receives exclusive global rights to Chimerix’s oral brincidofovir, including Tembexa, an FDA-approved medical countermeasure for smallpox, for US$325M; Chimerix in negotiations with BARDA for Tembexa procurement contract
Published:
May 20, 2022
by Marketline - Deals
|
FDA denies petitions to ban phthalates from food packaging and food production equipment; meanwhile, the agency will request new information regarding safety assessment for food-contact uses of phthalates
Published:
May 19, 2022
by Earthjustice
|
CDC considers expanding COVID-19 booster eligibility to people under 50 as cases rise to 94,000 per day, with seven-day case average rising 26% from the previous week and hospitalizations up 19% to 3,000 per day; additional dose requires FDA approval
Published:
May 19, 2022
by Reuters
|
Lupin Pharmaceuticals issues US recall of 3.3 million bottles of Losartan potassium tables, 3.9 million bottles of Losartan potassium and hydrochlorothiazide due to current good manufacturing practices; drugs made at Lupin's Madhya Pradesh, India, plant
Published:
May 18, 2022
by Accord Fintech
|
FDA lifts clinical hold on Gilead’s injectable lenacapavir HIV treatment, pre-exposure prophylaxis as Gilead changes borosilicate glass vials to aluminosilicate glass vials; hold was from concerns about drug’s compatibility with borosilicate vials
Published:
May 18, 2022
by Zack's Commentary
|
Ask us about our Government & Public Policy market view
Trending Chart
Interactive chart with headline count